Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cerebrovascular Diseases (Basel, Switzerland)|December 25, 2003
Cerebral ischemia: new risk factorsJaime Diaz, Angel P Sempere
Journal of Medical Case Reports|July 21, 2011
Bilateral optic neuritis in a 26-year-old man with common variable immunodeficiency: a case reportAngel P Sempere, Ml Tahoces, Susana Palao-Duarte, et al.
Multiple Sclerosis and Related Disorders|June 7, 2019
Multiple sclerosis prevalence and incidence in San Vicente del Raspeig, SpainNatalia Perez-Carmona, Juana Gimenez-Martinez, Cristina Borrego-Honrubia, et al.
Patient Preference and Adherence|February 17, 2017
Herding: a new phenomenon affecting medical decision-making in multiple sclerosis care? Lessons learned from DIScUTIR MSGustavo Saposnik, Jorge Maurino, Angel P Sempere, et al.
Journal of Neurology|September 23, 2025
Kappa free light chain index as a diagnostic and prognostic biomarker in multiple sclerosisLuis Moreno-Navarro, Sergio Mora-Diaz, Lourdes Ruiz-Escribano-Menchen, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|August 19, 2011
Response to immunotherapy in CLIPPERS: clinical, MRI, and MRS follow-upAngel P Sempere, Santiago Mola, Patricia Martin-Medina, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 27, 2019
Does attendance at the ECTRIMS congress impact on therapeutic decisions in multiple sclerosis care?Gustavo Saposnik, Jorge Maurino, Angel P Sempere, et al.
BMJ Open|March 10, 2017
Conjoint analysis to understand preferences of patients with multiple sclerosis for disease-modifying therapy attributes in Spain: a cross-sectional observational studyRafael Arroyo, Angel P Sempere, Elena Ruiz-Beato, et al.
Multiple Sclerosis and Related Disorders|April 9, 2025
Epidemiology of aquaporin-4 seropositive neuromyelitis optica spectrum disorder in the Alicante health area, Spain: A population-based studyLuis Moreno-Navarro, Monica Farrerons-Llopart, Sofia Lorenzo-Garcia, et al.
Neurology and Therapy|May 6, 2026
Real-World Effectiveness and Safety of Ofatumumab: Analysis of B Cell Depletion, Comorbidities and Ethnicity in a Spanish CohortLuis Moreno-Navarro, Lourdes Ruiz-Escribano-Menchen, Josefa Polache-Vengud, et al.
Pageof 2